Gubra A/S (CPSE:GUBRA) acquired Minigut Aps on June 29, 2023. The acquisition enables Gubra to perform minipig studies and adds a large animal model to Gubra?s CRO services. This includes both pharmacokinetic studies and microbiome studies, and over time additional minipig research models covering the disease areas within which Gubra operates.

Gubra A/S (CPSE:GUBRA) completed the acquisition of Minigut Aps for DKK 5.96 million on June 29, 2023. The purchase price paid for acquisition is DKK 5.96 million including a contingent payment of DKK 0.848 million.